Details for New Drug Application (NDA): 218642
✉ Email this page to a colleague
The generic ingredient in TOPIRAMATE is topiramate. There are twenty-six drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the topiramate profile page.
Summary for 218642
Tradename: | TOPIRAMATE |
Applicant: | Senores Pharms |
Ingredient: | topiramate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 15MG | ||||
Approval Date: | Oct 10, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 10, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription